Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D06KDU
|
|||
Former ID |
DIB019067
|
|||
Drug Name |
Tetrabromocinnamic acid
|
|||
Synonyms |
TBCA; tetrabromocinnamic acid
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL
|
|||
Formula |
C9H4Br4O2
|
|||
Canonical SMILES |
C1=C(C(=C(C(=C1Br)Br)Br)Br)C=CC(=O)O
|
|||
InChI |
1S/C9H4Br4O2/c10-5-3-4(1-2-6(14)15)7(11)9(13)8(5)12/h1-3H,(H,14,15)/b2-1+
|
|||
InChIKey |
SVJQCVOKYJWUBC-OWOJBTEDSA-N
|
|||
CAS Number |
CAS 934358-00-6
|
|||
PubChem Compound ID | ||||
PubChem Substance ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Casein kinase II (CSNK2) | Target Info | Inhibitor | [1] |
References | Top | |||
---|---|---|---|---|
REF 1 | Tetrabromocinnamic acid (TBCA) and related compounds represent a new class of specific protein kinase CK2 inhibitors. Chembiochem. 2007 Jan 2;8(1):129-39. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.